首页> 外文期刊>Asian Journal of Urology >Comparison of the oncological, perioperative and functional outcomes of partial nephrectomy versus radical nephrectomy for clinical T1b renal cell carcinoma: A systematic review and meta-analysis of retrospective studies
【24h】

Comparison of the oncological, perioperative and functional outcomes of partial nephrectomy versus radical nephrectomy for clinical T1b renal cell carcinoma: A systematic review and meta-analysis of retrospective studies

机译:临床T1B肾细胞癌的部分肾切除术与根治性肾切除术的肿瘤,围手术期和功能蛋白的比较:对回顾性研究的系统综述与荟萃分析

获取原文
       

摘要

ObjectiveTo conduct a meta-analysis assessing the perioperative, functional and oncological outcomes of partial nephrectomy (PN) and radical nephrectomy (RN) for T1b tumours. The primary endpoints were the oncological outcomes. The secondary endpoints were the perioperative and functional outcomes.MethodsA systematic literature review was performed by searching multiple databases through February 2019 to identify eligible comparative studies according to the Preferred Reporting Items for Systematic Review and Meta-analysis statement. Identified reports were assessed according to the Newcastle-Ottawa Scale for nonrandomized controlled trials.ResultsOverall, 13 retrospective cohort studies were included in the analysis. Patients undergoing PN were younger (weighted mean difference [WMD] ?3.49 years, 95% confidence interval [CI] ?5.16 to ?1.82;p<0.0001) and had smaller masses (WMD ?0.45?cm, 95% CI ?0.59 to ?0.31;p<0.0001). There were no differences in the oncological outcome, which was demonstrated by progression-free survival (hazard ratio [HR] 0.70;p=0.22), cancer-specific mortality (HR 0.91;p=0.57) and all-cause mortality (HR 1.01;p=0.96). The two procedures were similar in estimated blood loss (WMD ?16.47?mL;p=0.53) and postoperative complications (risk ratio [RR] 1.32;p=0.10), and PN provided better renal function preservation and was related to a lower likelihood of chronic kidney disease onset (RR 0.38;p=0.006).ConclusionPN is an effective treatment for T1b tumours because it offers similar surgical morbidity, equivalent cancer control, and better renal preservation compared to RN.
机译:ObjectiveRo进行荟萃分析,评估部分肾切除术(Pn)的围手术,功能和肿瘤蛋白和肿瘤肾切除术(RN)的围手术期,功能和肿瘤蛋白。主要终点是肿瘤的结果。次要终点是围手术期和功能的结果。通过2019年2月搜索多个数据库来识别根据首选报告项目进行系统审查和Meta-Analysis陈述的首选报告项目来进行方法系统文献综述。根据Newcastle-渥太华规模评估了已识别的报告,用于非扫描控制试验。分析中包括13项回顾性队列研究。接受PN的患者更年轻(加权平均差异[WMD]?3.49岁,95%置信区间[CI]?5.16至?1.82; P <0.0001)并具有较小的质量(WMD?0.45?CM,95%CI?0.59至95%CI?0.59 ?0.31; p <0.0001)。肿瘤生存(危害比[HR] 0.70; P = 0.22),癌症特异性死亡率(HR 0.91; P = 0.57)和全因死亡率(HR 1.01)和全部原因死亡率(HR 1.01)(HR 1.01)和全部原因死亡率(HR 1.01 ; p = 0.96)。这两种程序在估计的血液损失(WMD?16.47?mL; P = 0.53)和术后并发症(风险比[RR] 1.32; P = 0.10),并且PN提供了更好的肾功能保存,并且与较低的可能性有关慢性肾病发作(RR 0.38; p = 0.006).Conclusionpn是T1B肿瘤的有效治疗,因为它提供了与RN相比具有相似的手术发病率,当量癌症控制和更好的肾脏保存。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号